(Q36939901)

17 August 2017

1 reference

title

Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting (English)

1 reference

17 August 2017

1 reference

1 reference

Ruurd Torensma

0 references

Carl G Figdor

0 references

Paul J Tacken

1 reference

17 August 2017

I Jolanda M de Vries

series ordinal

1 reference

17 August 2017

language of work or name

1 reference

1 October 2007

1 reference

Nature Reviews Immunology

17 August 2017

published in

1 reference

17 August 2017

1 reference

17 August 2017

1 reference

17 August 2017

page(s)

790-802

1 reference

Dendritic cells and the control of immunity

17 August 2017

cites work

1 reference

Antibodies to Hepatitis B Surface Antigen Potentiate the Response of Human T Lymphocyte Clones to the Same Antigen

31 March 2020

1 reference

Regulation of immune response by antibodies: the importance of antibody and monocyte Fc receptor interaction in T-cell activation

31 March 2020

1 reference

Adjuvant-free IgG responses induced with antigen coupled to antibodies against class II MHC.

31 March 2020

1 reference

Enhanced antigen immunogenicity induced by bispecific antibodies

31 March 2020

1 reference

C-type lectin receptors on dendritic cells and Langerhans cells

31 March 2020

1 reference

Mannose receptor-targeted vaccines

31 March 2020

1 reference

Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein

31 March 2020

1 reference

Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835].

31 March 2020

1 reference

A Novel Human Cancer Vaccine Elicits Cellular Responses to the Tumor-Associated Antigen, Human Chorionic Gonadotropin

31 March 2020

1 reference

Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules

31 March 2020

1 reference

Antigenic targeting of the human mannose receptor induces tumor immunity

31 March 2020

1 reference

Antigen to the node: B cells go native

31 March 2020

1 reference

The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments

31 March 2020

1 reference

Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. I. Expression on dendritic cells and other subsets of mouse leukocytes

31 March 2020

1 reference

Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance

31 March 2020

1 reference

Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo

31 March 2020

1 reference

Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells

31 March 2020

1 reference

In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination

31 March 2020

1 reference

Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy

31 March 2020

1 reference

Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses

31 March 2020

1 reference

Targeting of antigens to activated dendritic cells in vivo cures metastatic melanoma in mice

31 March 2020

1 reference

DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes

31 March 2020

1 reference

Expression of human DEC-205 (CD205) multilectin receptor on leukocytes.

31 March 2020

1 reference

Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses

31 March 2020

1 reference

Evidence that multiple defects in murine DC-SIGN inhibit a functional interaction with pathogens

31 March 2020

1 reference

Functional comparison of mouse CIRE/mouse DC-SIGN and human DC-SIGN

31 March 2020

1 reference

Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody.

31 March 2020

1 reference

Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction

31 March 2020

1 reference

Mouse and human dendritic cell subtypes

31 March 2020

1 reference

CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.

31 March 2020

1 reference

Differential antigen processing by dendritic cell subsets in vivo

31 March 2020

1 reference

Molecular cloning of F4/80-like-receptor, a seven-span membrane protein expressed differentially by dendritic cell and monocyte-macrophage subpopulations

31 March 2020

1 reference

Molecular cloning of a C-type lectin superfamily protein differentially expressed by CD8alpha(-) splenic dendritic cells

31 March 2020

1 reference

Anatomic location and T-cell stimulatory functions of mouse dendritic cell subsets defined by CD4 and CD8 expression

31 March 2020

1 reference

Antigen delivery via two molecules on the CD8- dendritic cell subset induces humoral immunity in the absence of conventional "danger".

31 March 2020

1 reference

Preferential induction of CD4+ T cell responses through in vivo targeting of antigen to dendritic cell-associated C-type lectin-1

31 March 2020

1 reference

Internalizing antibodies to the C-type lectins, L-SIGN and DC-SIGN, inhibit viral glycoprotein binding and deliver antigen to human dendritic cells for the induction of T cell responses

31 March 2020

1 reference

Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages

31 March 2020

1 reference

Human antibody-Fc receptor interactions illuminated by crystal structures

31 March 2020

1 reference

Fcgamma receptors: old friends and new family members

31 March 2020

1 reference

Dendritic cell immunoreceptors: C-type lectin receptors for pattern-recognition and signaling on antigen-presenting cells.

31 March 2020

1 reference

Dectin-1 activates Syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production

31 March 2020

1 reference

Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins

31 March 2020

1 reference

Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2.

31 March 2020

1 reference

Mycobacteria target DC-SIGN to suppress dendritic cell function

31 March 2020

1 reference

BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction

31 March 2020

1 reference

Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells

31 March 2020

1 reference

Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein

31 March 2020

1 reference

Triggering TLR signaling in vaccination

31 March 2020

1 reference

A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells

31 March 2020

1 reference

Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity

31 March 2020

1 reference

Altered expression and endocytic function of CD205 in human dendritic cells, and detection of a CD205-DCL-1 fusion protein upon dendritic cell maturation.

31 March 2020

1 reference

A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses

31 March 2020

1 reference

An adenoviral vector cancer vaccine that delivers a tumor-associated antigen/CD40-ligand fusion protein to dendritic cells

31 March 2020

1 reference

Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation

31 March 2020

1 reference

Immunization with HIV-1 Gag protein conjugated to a TLR7/8 agonist results in the generation of HIV-1 Gag-specific Th1 and CD8+ T cell responses.

31 March 2020

1 reference

Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism

31 March 2020

1 reference

Toll-like receptor recognition regulates immunodominance in an antimicrobial CD4+ T cell response

31 March 2020

1 reference

Toll-dependent selection of microbial antigens for presentation by dendritic cells

31 March 2020

1 reference

Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells

31 March 2020

1 reference

Toll-like receptor activation enhances cell-mediated immunity induced by an antibody vaccine targeting human dendritic cells

31 March 2020

1 reference

Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation.

31 March 2020

1 reference

Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo

31 March 2020

1 reference

Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis

31 March 2020

1 reference

ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells

31 March 2020

1 reference

Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells.

31 March 2020

1 reference

Cells process exogenous proteins for recognition by cytotoxic T lymphocytes

31 March 2020

1 reference

Introduction of soluble protein into the class I pathway of antigen processing and presentation

31 March 2020

1 reference

Arginine-rich cell penetrating peptides: from endosomal uptake to nuclear delivery

31 March 2020

1 reference

Protein transduction of dendritic cells for NY-ESO-1-based immunotherapy of myeloma

31 March 2020

1 reference

Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity

31 March 2020

1 reference

Virus membrane-fusion proteins: more than one way to make a hairpin

31 March 2020

1 reference

Functional characterization of an endosome-disruptive peptide and its application in cytosolic delivery of immunoliposome-entrapped proteins

31 March 2020

1 reference

Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis.

31 March 2020

1 reference

Enhanced major histocompatibility complex class I-dependent presentation of antigens modified with cationic and fusogenic peptides.

31 March 2020

1 reference

In vivo protein transduction: delivery of a biologically active protein into the mouse

31 March 2020

1 reference

DermaVir: a novel topical vaccine for HIV/AIDS.

31 March 2020

1 reference

Control of viral rebound through therapeutic immunization with DermaVir

31 March 2020

1 reference

Genetic medicines: treatment strategies for hereditary disorders

31 March 2020

1 reference

Biopharmaceutical benchmarks 2006.

31 March 2020

1 reference

High efficiency transduction of dendritic cells by adenoviral vectors targeted to DC-SIGN.

31 March 2020

1 reference

An adenovirus vector with a chimeric fiber incorporating stabilized single chain antibody achieves targeted gene delivery

31 March 2020

1 reference

Analysis of protease activity in live antigen-presenting cells shows regulation of the phagosomal proteolytic contents during dendritic cell activation

31 March 2020

1 reference

Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate

31 March 2020

1 reference

Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis

31 March 2020

1 reference

PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines

31 March 2020

1 reference

NOX2 Controls Phagosomal pH to Regulate Antigen Processing during Crosspresentation by Dendritic Cells

31 March 2020

1 reference

Chloroquine enhances human CD8+ T cell responses against soluble antigens in vivo

31 March 2020

1 reference

Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII.

31 March 2020

1 reference

Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products

31 March 2020

1 reference

Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes

31 March 2020

1 reference

Altered peptidase and viral-specific T cell response in LMP2 mutant mice.

31 March 2020

1 reference

An altered T cell repertoire in MECL-1-deficient mice

31 March 2020

1 reference

Processing of tumor-associated antigen by the proteasomes of dendritic cells controls in vivo T-cell responses.

31 March 2020

1 reference

Tregs and rethinking cancer immunotherapy

31 March 2020

1 reference

Mature Human Langerhans Cells Derived from CD34+ Hematopoietic Progenitors Stimulate Greater Cytolytic T Lymphocyte Activity in the Absence of Bioactive IL-12p70, by Either Single Peptide Presentation or Cross-Priming, Than Do Dermal-Interstitial or

31 March 2020

1 reference

Plasmacytoid dendritic cells of melanoma patients present exogenous proteins to CD4+ T cells after Fc gamma RII-mediated uptake

31 March 2020

1 reference

Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors

31 March 2020

1 reference

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

31 March 2020

1 reference

Migration of dendritic cell based cancer vaccines: in vivo veritas?

31 March 2020

1 reference

Prospects for exosomes in immunotherapy of cancer

31 March 2020

1 reference

The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells

31 March 2020

1 reference

Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice

31 March 2020

1 reference

Regulated expression of FcgammaR in human dendritic cells controls cross-presentation of antigen-antibody complexes.

31 March 2020

1 reference

Highly efficient antigen targeting to M-DC8+ dendritic cells via FcgammaRIII/CD16-specific antibody conjugates

31 March 2020

1 reference

Inefficient antigen presentation via the IgA Fc receptor (FcalphaRI) on dendritic cells

31 March 2020

1 reference

Delivery of multiple epitopes by recombinant detoxified adenylate cyclase of Bordetella pertussis induces protective antiviral immunity

31 March 2020

1 reference

Anti-viral protection conferred by recombinant adenylate cyclase toxins from Bordetella pertussis carrying a CD8+ T cell epitope from lymphocytic choriomeningitis virus

31 March 2020

1 reference

In vivo induction of CTL responses by recombinant adenylate cyclase of Bordetella pertussis carrying multiple copies of a viral CD8(+) T-cell epitope

31 March 2020

1 reference

Proliferating dendritic cell progenitors in human blood

31 March 2020

1 reference

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

31 March 2020

1 reference

Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells

31 March 2020

1 reference

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

31 March 2020

1 reference

Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.

31 March 2020

1 reference

Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells

31 March 2020

1 reference

Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy

31 March 2020

1 reference

Dendritic cells injected via different routes induce immunity in cancer patients

31 March 2020

1 reference

Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control

31 March 2020

1 reference

Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans

31 March 2020

1 reference

A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection.

31 March 2020

1 reference

Phase I trial of intravenous peptide-pulsed dendritic cells in patients with metastatic melanoma

31 March 2020

1 reference

Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy

31 March 2020

1 reference

Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells.

31 March 2020

1 reference

Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells.

31 March 2020

1 reference

Induction of Tumor-Specific Cytotoxic T Lymphocytes in Cancer Patients by Autologous Tumor RNA-Transfected Dendritic Cells

31 March 2020

1 reference

Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA

31 March 2020

1 reference

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

31 March 2020

1 reference

Mucin gene (MUC1) transfected dendritic cells as vaccine: results of a phase I/II clinical trial

31 March 2020

1 reference

Immune and clinical outcomes in patients with stage IV melanoma vaccinated with peptide-pulsed dendritic cells derived from CD34+ progenitors and activated with type I interferon.

31 March 2020

1 reference

A new dendritic cell vaccine generated with interleukin-3 and interferon-β induces CD8+ T cell responses against NA17-A2 tumor peptide in melanoma patients

31 March 2020

1 reference

Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial

31 March 2020

1 reference

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

31 March 2020

1 reference

Allogeneic dendritic cell vaccination against metastatic renal cell carcinoma with or without cyclophosphamide.

31 March 2020

1 reference

Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications

31 March 2020

1 reference

Immunotherapy of patients with hormone-refractory prostate carcinoma pre-treated with interferon-gamma and vaccinated with autologous PSA-peptide loaded dendritic cells--a pilot study

31 March 2020

1 reference

Allogeneic Dendritic Cells Fused with Tumor Cells: Preclinical Results and Outcome of a Clinical Phase I/II Trial in Patients with Metastatic Renal Cell Carcinoma

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRI2173

1 reference

Dimensions Publication ID

17 August 2017

1009390941

0 references

1 reference